Rates and types of urine drug screen false negative results compared with confirmatory toxicology testing in major trauma patients

References

• Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83(1):66–76.
   PubMed Web of Science ®Google Scholar
• Moeller KE, Kissack JC, Atayee RS, et al. Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens. Mayo Clin Proc. 2017;92(5):774–796.
   PubMed Web of Science ®Google Scholar
• Saitman A, Park H-D, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol. 2014;38(7):387–396.
   PubMed Web of Science ®Google Scholar
• Mikkelsen S, Ash K. Adulterants causing false negatives in illicit drug testing. Clin Chem. 1988;34(11):2333–2336.
   PubMed Web of Science ®Google Scholar
• Riederer AM, Campleman SL, Carlson RG, et al. Acute poisonings from synthetic cannabinoids—50 US toxicology investigators consortium registry sites, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(27):692–695.
   PubMed Web of Science ®Google Scholar
• Gilley M, Brent J, Calello DP, et al. Synthetic cannabinoid exposure in adolescents presenting for emergency care. Pediatr Emer Care. 2021;37(1):e13–e16.
   PubMed Web of Science ®Google Scholar
• Sloan EP, Zalenski RJ, Smith RF, et al. Toxicology screening in urban trauma patients: drug prevalence and its relationship to trauma severity and management. J Trauma. 1989;29(12):1647–1653.
   PubMedGoogle Scholar
• Madan AK, Yu K, Beech DJ. Alcohol and drug use in victims of life-threatening trauma. J Trauma Acute Care Surg. 1999;47(3):568–571.
   Google Scholar
• Langdorf M, Rudkin S, Dellota K, et al. Decision rule and utility of routine urine toxicology screening of trauma patients. Eur J Emerg Med. 2002;9(2):115–121.
   PubMedGoogle Scholar
• London JA, Battistella FD. Testing for substance use in trauma patients: are we doing enough? Arch Surg. 2007;142(7):633–638.
   PubMedGoogle Scholar
• Parran TV, Weber E, Tasse J, et al. Mandatory toxicology testing and chemical dependence consultation follow-up in a level-one trauma center. J Trauma Acute Care Surg. 1995;38(2):278–280.
   Google Scholar
• Blondell RD, Dodds HN, Looney SW, et al. Toxicology screening results: injury associations among hospitalized trauma patients. J Trauma Acute Care Surg. 2005;58(3):561–570.
   Google Scholar
• Soderstrom CA, Dischinger PC, Smith GS, et al. Psychoactive substance dependence among trauma center patients. JAMA. 1992;267(20):2756–2759.
   PubMed Web of Science ®Google Scholar
• Soderstrom CA, Smith GS, Dischinger PC, et al. Psychoactive substance use disorders among seriously injured trauma center patients. JAMA. 1997;277(22):1769–1774.
   PubMed Web of Science ®Google Scholar
• Guardia SC, Rodríguez-Bolaños S, López FG, et al. Alcohol and/or drug abuse favors trauma recurrence and reduces the trauma-free period. Medicina Intensiva. 2013;37(1):6–11.
   PubMed Web of Science ®Google Scholar
• Walsh JM, Flegel R, Atkins R, et al. Drug and alcohol use among drivers admitted to a level-1 trauma center. Accid Anal Prev. 2005;37(5):894–901. 2005/09/01/
   PubMed Web of Science ®Google Scholar
• Ehrlich PF, Brown JK, Drongowski R. Characterization of the drug-positive adolescent trauma population: should we, do we, and does it make a difference if we test? J Pediatric Surg. 2006;41(5):927–930.
   PubMed Web of Science ®Google Scholar
• Demetriades D, Gkiokas G, Velmahos GC, et al. Alcohol and illicit drugs in traumatic deaths: prevalence and association with type and severity of injuries. J Am Coll Surg. 2004;199(5):687–692.
   PubMed Web of Science ®Google Scholar
• Cheng V, Inaba K, Johnson M, et al. The impact of pre-injury controlled substance use on clinical outcomes following trauma. J Trauma Acute Care Surg. 2016;81(5):913–920.
   PubMed Web of Science ®Google Scholar
• Bast RP, Helmer SD, Henson SR, et al. Limited utility of routine drug screening in trauma patients. South Med J. 2000;93(4):397–399.
   PubMed Web of Science ®Google Scholar
• Cornwell EE, IIIBelzberg H, Velmahos G, et al. The prevalence and effect of alcohol and drug abuse on cohort-matched critically injured patients. Am Surg. 1998;64(5):461.
   PubMed Web of Science ®Google Scholar
• Ekeh AP, Parikh PP, Walusimbi M, et al. The prevalence of positive drug and alcohol screens in elderly trauma patients. Subst Abus. 2014;35(1):51–55.
   PubMed Web of Science ®Google Scholar
• Walsh JM, Flegel R, Cangianelli LA, et al. Epidemiology of alcohol and other drug use among motor vehicle crash victims admitted to a trauma center. Traffic Inj Prev. 2004;5(3):254–260.
   PubMedGoogle Scholar
• Lank PM, Crandall ML. Outcomes for older trauma patients in the emergency department screening positive for alcohol, cocaine, or marijuana use. Am J Drug Alcohol Abuse. 2014;40(2):118–124.
   PubMed Web of Science ®Google Scholar
• Cowperthwaite MC, Burnett MG. Treatment course and outcomes following drug and alcohol-related traumatic injuries. J Trauma Manag Outcomes. 2011;5(1):3.
   PubMedGoogle Scholar
• Tominaga GT, Garcia G, Dzierba A, et al. Toll of methamphetamine on the trauma system. Arch Surg. 2004;139(8):844–847.
   PubMedGoogle Scholar
• Pandya U, O'Mara MS, Wilson W, et al. Impact of preexisting opioid use on injury mechanism, type, and outcome. J Surg Res. 2015;198(1):7–12.
   PubMed Web of Science ®Google Scholar
• Dischinger PC, Mitchell KA, Kufera JA, et al. A longitudinal study of former trauma center patients: the association between toxicology status and subsequent injury mortality. J Trauma Acute Care Surg. 2001;51(5):877–886.
   Web of Science ®Google Scholar
• Soderstrom CA, Dischinger PC, Kerns TJ, et al. Epidemic increases in cocaine and opiate use by trauma center patients: documentation with a large clinical toxicology database. J Trauma Acute Care Surg. 2001;51(3):557–564.
   Google Scholar
• Cordovilla-Guardia S, García-Jiménez C, Fernández-Mondéjar E, et al. Association between the detection of alcohol, illicit drugs and/or psychotropic medications/opioids in patients admitted due to trauma and trauma recidivism: a cohort study. PLoS ONE. 2018;13(9):e0203963.
   PubMed Web of Science ®Google Scholar
• Cannon R, Bozeman M, Miller KR, et al. The prevalence and impact of prescription controlled substance use among injured patients at a level I trauma center. J Trauma Acute Care Surg. 2014;76(1):172–175.
   PubMed Web of Science ®Google Scholar
• Twillman RK, Dawson E, LaRue L, et al. Evaluation of trends of near-real-time urine drug test results for methamphetamine, cocaine, heroin, and fentanyl. JAMA Netw Open. 2020;3(1):e1918514-e1918514.
   Web of Science ®Google Scholar
• Trauma ACoSCo. Alcohol screening and brief intervention (SBI) for trauma patients. Committee on Trauma Quick Guide Chicago: ASCOT; 2007.
   Google Scholar
• Bulger EM, Johnson P, Parker L, et al. Nationwide survey of trauma center screening and intervention practices for posttraumatic stress disorder, firearm violence, mental health, and substance use disorders. J Am Coll Surg. 2022;234(3):274–287.
   PubMed Web of Science ®Google Scholar
• Bogenschutz MP, Donovan DM, Mandler RN, et al. Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial. JAMA Intern Med. 2014;174(11):1736–1745.
   PubMed Web of Science ®Google Scholar
• Veach LJ, Moro RR, Miller P, et al. Alcohol counseling in hospital trauma: examining two brief interventions. Journal of Counseling & Development. 2018;96(3):243–253.
   Web of Science ®Google Scholar
• Huang AR, Mallet L, Rochefort CM, et al. Medication-related falls in the elderly. Drugs Aging. 2012;29(5):359–376.
   PubMed Web of Science ®Google Scholar
• Halli-Tierney A, Scarbrough C, Carroll DG. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100(1):32–38.
   PubMed Web of Science ®Google Scholar
• Rogers JL, Bernard JM, Veach LJ, et al. Brief counseling for alcohol misuse among trauma patients: two interventions and influence of baseline use. J Addict Offender Counsel. 2018;39(2):89–105.
   Web of Science ®Google Scholar
• Panel A, Fick DM, Semla TP, et al. American geriatrics society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694.
   PubMed Web of Science ®Google Scholar
• Kim HS, McCarthy DM, Lank PM. Tramadol, codeine, and risk of adverse outcomes. JAMA. 2021;326(15):1483–1484.
   PubMed Web of Science ®Google Scholar
• Clarke SED, Kral AH, Zibbell JE. Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market. Int J Drug Policy. 2022;99:103467.
   PubMed Web of Science ®Google Scholar
• Smith RV, Havens JR, Walsh SL. Gabapentin misuse, abuse and diversion: a systematic review. Addiction. 2016;111(7):1160–1174.
   PubMed Web of Science ®Google Scholar
• Gomes T, Juurlink DN, Antoniou T, et al. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case–control study. PLoS Med. 2017;14(10):e1002396.
   PubMed Web of Science ®Google Scholar
• Samet JM. Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Surg Clin. 2013;23(2):103–112.
   PubMed Web of Science ®Google Scholar
• Cornelius ME, Wang TW, Jamal A, et al. Tobacco product use among adults—United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(46):1736–1742.
   PubMed Web of Science ®Google Scholar
• Kalman D, Morissette SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict. 2005;14(2):106–123.
   PubMed Web of Science ®Google Scholar
• McNeely J, Wu L-T, Subramaniam G, et al. Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients. Ann Intern Med. 2016;165(10):690–699.
   PubMed Web of Science ®Google Scholar